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Summary
Objective: Long-term storage of articular cartilage (AC) remains challenging due to poor post-thaw viability. An initial step towards addressing
this issue is characterizing cryoprotectant (CPA) transport, since ensuring adequate CPA equilibration throughout the tissue offers protection
during cooling. This study takes a systematic approach in determining CPA transport rates through bovine AC and uses that information in
mathematical models to determine CPA equilibration times.
Design: Diffusion of high concentration single (6.9 M dimethyl sulfoxide (DMSO)) and multi-component CPA solutions (VS55, 3.1 M
DMSOþ 2.2 M 1,2-propanediol (PD)þ 3.1 M formamide (FM)) was measured through AC using 1H nuclear magnetic resonance (NMR) im-
aging and localized spectroscopy, respectively. Using experimentally calculated effective diffusivities, diffusion models describing CPA trans-
port through the tissue matrix and across chondrocyte membranes were combined to design a CPA addition and removal scheme for
a cartilage plug of clinically relevant dimensions.
Results: 1H NMR imaging and localized spectroscopy experiments suggested that the permeation of CPAs through AC (5 mm diameter,
5e10 mm in thickness) took on the order of 4 h for full equilibration at 22C. Imaging clearly showed the permeation of DMSO into cartilage
over time and localized spectroscopy was able to distinguish the permeation rates of the individual VS55 components and water. Experimen-
tally measured diffusivity values were used in CPA addition/removal simulations with a cartilage plug of clinically relevant dimensions (5 mm
diameter, 2 mm in thickness). Results suggested a multi-step approach for adding and removing high concentration CPAs, with the addition
and removal each taking approximately 2 h to complete.
Conclusions: This study provides a foundation for designing CPA addition and removal protocols for effective long-term storage of cartilage
tissue using a novel approach to measure CPA permeation.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Transplantation of fresh osteochondral allografts has
proven to be effective for clinical treatment of focal articular
defects. However, the limited availability of fresh allograft
tissues necessitates banking for long-term storage1e4. Al-
though cryopreservation by freezing is preferable for long-
term tissue storage, conventional protocols result in high
cell death of the chondrocytes along with the formation of
ice in the matrix and/or in the chondrons5e7. Indeed, there*Address correspondence and reprint requests to: Dr
Athanassios Sambanis, Ph.D., School of Chemical &
Biomolecular Engineering, Georgia Institute of Technology, 315
Ferst Drive, IBB Building, Room 1306, Atlanta, GA 30332, USA.
Tel: 1-404-894-2869; Fax: 1-404-894-2291; E-mail: athanassios.
sambanis@chbe.gatech.edu
Received 8 August 2007; revision accepted 30 March 2008.
1379exists evidence that, although extracellular ice is generally
not harmful to suspensions of single cells, it poses a major
hazard for natural and artiﬁcial tissues4,8e10 and recent
studies indicate that extracellular ice forms within the chon-
dron of cartilage causing cell damage7. Therefore, improved
preservation methods are needed as part of a successful
clinical application.
Ice-free cryopreservation, or vitriﬁcation, which involves
the amorphous solidiﬁcation of a liquid in the absence of ice
crystals, has the potential to achieve tissue preservation by
maintaining cellular viability and functionality, as well as in-
tegrity and function of the extracellular matrix5,11e13. Vitriﬁca-
tion is generally accomplished through combination of high
concentrations of cryoprotectants (CPAs) and rapid cooling
and warming rates so that nucleation and growth of ice crys-
tals are effectively minimized. Alternatively, recent work has
shown that vitriﬁcation can be achieved by tracking the
liquidus line, i.e., by gradually increasing the CPA
Fig. 1. Schematic of NMR sample holder. (A) Field of view of the
radiofrequency coil; (B) 50 mL centrifuge tube; (C) Teﬂon piece
holding tissue culture insert in place; (D) 10 mm diameter tissue cul-
ture insert with 8 mm pore size membrane; (E) cartilage plug; (F)
VOI for localized spectroscopy studies; (G) 1.0 mm thick plane for
CPA imaging studies. The Teﬂon piece rested on the walls of the
centrifuge tube and had a hole of diameter slightly smaller than
the diameter of the insert to ensure exposure of the membrane of
the latter to the liquid solution. Bo¼magnetic ﬁeld; ﬁgure not drawn
to scale.
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case, vitriﬁcation of samples of clinically relevant thickness
is particularly challenging. Characterizing mass transport
properties of CPAs through articular cartilage (AC) is critical
in addressing issues of cellular osmotic volume excursions
and cytotoxicity to confer protection during cooling.
Nuclear magnetic resonance (NMR) imaging and spectros-
copy are powerful, non-invasive tools that can be employed to
monitor thepermeation into tissuesofCPAswithNMR-observ-
able nuclei. NMR imaging can be used to obtain spatial infor-
mation of CPA distribution at various times, revealing
heterogeneities inCPAdiffusionwithin the tissue.MR imaging
techniques have been used to observe and quantify CPA per-
meation into various tissues including freeze-dried artiﬁcial
dermal replacements15, rat kidney and liver16, zebraﬁsh em-
bryos17 and human AC18. As is often the case in vitriﬁcation,
however, multi-solute solutions are used12,19 and acquiring si-
multaneously the transport rates of all components of theCPA
cocktail is essential for accuracy. NMR spectroscopy can be
used to determine precise concentrations of multiple solutes
simultaneously. Previously, NMR spectroscopy has been
used as an ofﬂine tool to determine the permeation kinetics
ofCPAs intoACbymeasuring the concentration in thebulk so-
lution20; in those studies, however, solutions containing a sin-
gle CPA were used.
In this study, we addressed the critical issue of delivering
and removing high concentrations of CPAs necessary for vit-
riﬁcation in AC. We utilized immature bovine AC, as this tis-
sue is available, inexpensive, and can be prepared in the
necessary dimensions to effectively study CPA transport.
Furthermore, the developedmethodologies can be easily ex-
tended to human cartilage. Diffusion of a single and multi-
component CPAs were studied, and effective diffusivities
were calculated. Equations for CPA transport through the ex-
tracellular matrix were coupled with equations for transport
through the cell membrane. The model was used to design
stepwise CPA addition and removal protocols, which mini-
mized osmotic effects on cells, and to determine CPA equili-
bration times for tissue of clinically relevant dimensions. The
use of this information in designing optimized cryopreserva-
tion protocols is discussed.Materials and methodsCHEMICALSUnless otherwise stated, all chemicals were purchased at Sigma Chem-
ical Company (St. Louis, MO, USA).TISSUE ISOLATIONFull thickness AC plugs (without bone) were harvested from the femoral
condyle or femoropatellar groove of 1e2 week old calves (Research 87,
Marlborough, MA) using an 8 mm sterile disposable biopsy punch (Miltex,
Inc., York, PA, USA). Cartilage plugs isolated were 8 mm in diameter and be-
tween 5 mm and 10 mm in thickness.MR IMAGING SETUP, ACQUISITION AND ANALYSISA cartilage plug was placed in a sample holder consisting of an 8 mm pore
size membrane tissue culture insert (BD Biosciences, Franklin Lakes, NJ,
USA) placed on top of a cut Teﬂon sheet with a hole of diameter slightly
smaller than the diameter of the insert to ensure exposure of the membrane
of the latter to the liquid solution. These were all contained within a 50 mL
centrifuge tube (VWR International, Suwanee, GA, USA) (Fig. 1). The large
pore size of the insert membrane prevented any mass transfer resistance of
solute to the cartilage surface. The tube was ﬁlled with a 6.9 M DMSO solu-
tion (50% w/w) in 1 phosphate buffered saline (PBS) and quickly placed in
a 3.8 cm inner diameter quadrature birdcage resonator. Imaging was per-
formed on a Varian/Inova spectroscopy and imaging system operating at
4.7 T (200.536 MHz at 22C). A gradient insert (11.7 cm id) was enclosedin an outer standard gradient coil. The maximum gradient amplitude was
25 gauss/cm with a rise time of 250 ms. The ﬁnal tissue orientation was
such that the plane of the disk was parallel to the applied magnetic ﬁeld di-
rection. Following shimming to create a homogenous magnetic ﬁeld and
scout imaging to locate the imaging plane, a chemical shift selective imaging
(CSSI) sequence was utilized to visualize diffusion of DMSO into the tissue.
In the pulse sequence utilized, the initial 90 16 ms Gaussian pulse was
chemical shift selective, but not slice selective. Slice selection was achieved
with the 180 refocusing pulse which consisted of a 2 ms sinc waveform. Two
hundred and ﬁfty six complex points were acquired in the read direction with
128 phase encoding steps. The data matrix was zero ﬁlled to 512 512 be-
fore 2-D Fourier transformation. The chosen ﬁeld of view (4 cm 4 cm) gave
a ﬁnal in-plane displayed resolution of 78 mm 78 mm with a slice thickness
of 1 mm. Four acquisitions were averaged for each image slice centered
within the sample. The total imaging time for each scan was 51 min.
DMSO permeation was examined by monitoring the signal intensity over
time. Mean brightness intensities inside the cartilage and in the bulk were de-
termined for each image using freeware ImageJ analysis software (National
Institutes of Health, USA). The mean intensities inside the tissue were nor-
malized to the mean external solution intensity (Icartilage/Ibulk).
To aid in the proper choice of echo (TE) and repetition times (TR) during
CSSI acquisition, relaxation parameters T1 (by inversion recovery) and T2
(CarrePurcelleMeiboomeGill, CPMG), were determined for the bulk CPA so-
lution and within an equilibrated cartilage sample. Consequently, TE and TR
were adjusted to reﬂect these relaxation times. T1 effects were assumed neg-
ligible due to long TR times used. Apparent T2 effects were estimated by taking
images at different TE values for tissue equilibrated with the DMSO solution.
Images were obtained from eight TE values (23 ms, 43 ms, 83 ms, 123 ms,
143 ms, 183 ms, 223 ms, and 263 ms) and were ﬁt to the equation,
M(t)¼Mo exp(t/T2), using an MR Analysis Calculator plug-in (author: Karl
Schmidt) for ImageJ to yield T2 andMo values, whereM(t) is themagnetization
vector at time t,Mo is the equilibriummagnetization vector, and T2 is the trans-
verse relaxation time decay constant. Tissue and bathing solution image
intensities could then be corrected for the effect of different apparentT2 values.
The CPA concentration inside or outside the tissue is proportional to Mo
in the respective position and the intensities are proportional to M(t) (i.e.,
I inside/Ioutside¼M(t)inside/M(t)outside). Hence, the ratio of intensities was multi-
plied by a T2 factor to take into account these effects. For images acquired at
TE¼ 23 ms (assuming constant T2 inside the tissue),
C inside
Coutside
¼ M
inside
o
Moutsideo
¼ I
inside e
TE
T2
Ioutside e
TE
T2
¼ I
inside e
23 ms
1045 ms
Ioutside e
23 ms
116 ms
ð1Þ
where C is the CPA concentration; Mo the equilibrium magnetization vector;
I the signal intensity; T2 the transverse relaxation time decay constant; inside
refers to the cartilage sample, outside refers to the bulk solution.
Based on Eq. (1), the raw intensity data inside the tissue were corrected
for T2 effects by multiplying by (e
23 ms/1045 ms)/(e23 ms/116 ms)¼ 1.19. We
considered the effects of molecular translational self diffusion on the decay
of the MR signal during both the imaging and spectroscopy sequences,
and determined that these are negligible relative to the measurements under
our experimental conditions (less than 5%).MR SPECTROSCOPY SETUP, ACQUISITION AND ANALYSISA cartilage plug was positioned in the magnet as above, standard 1H NMR
gradient-echo scout images were acquired to locate the imaging plane, and
localized 1H NMR spectra were acquired from a 1 1 1 mm3 voxel or
1381Osteoarthritis and Cartilage Vol. 16, No. 11volume of interest (VOI), centered within the cartilage plug using a localized
point resolved spectroscopy sequence (PRESS)21. The ﬁnal tissue orienta-
tion was the same as in the imaging experiments. Shimming of the water sig-
nal was performed on the selected VOI using a localized PRESS sequence.
The cartilage plug was initially submerged in 1 PBS and the water con-
tent in the sample was measured. The PBS was completely removed and re-
placed with half strength of vitriﬁcation solution VS55 (1.55 M dimethyl
sulfoxide (DMSO), 1.1 M 1,2-propanediol (PD), 1.55 M formamide
(FM))5,11,19 in PBS at 22C. The time from introducing the CPA solution to
attaining the ﬁrst spectrum was 30 min. The time required to collect each
spectrum was 12 min, and data were acquired for approximately 6 h.
Spectral data were processed using the frequency domain analysis pack-
age supplied in VNMR (Varian). Time domain data were apodized with an
exponential line broadening of 5 Hz, Fourier transformed, and baseline cor-
rected where necessary. A Lorentzian function was ﬁt to the resulting peaks
and integrated to determine the area under each peak, which is proportional
to the respective solute concentration.MATHEMATICAL MODELING AND CALCULATIONSMulti-solute CPA transport within the cartilage plug was simulated with
a two-compartment model to characterize diffusion within the cartilage matrix
and across the chondrocyte cell membrane.
Model assumptions
1. No CPA reaction or consumption by the cells or matrix.
2. Uniform cell distribution. This is a good assumption for immature carti-
lage where the cell distribution is relatively homogenous22e24.
3. Isotropic effective diffusivities. The low molecular weight, non-electro-
lyte nature of the CPA solutes makes the isotropic transport assump-
tion reasonable.
4. Isothermal experimental conditions.
5. Constant cell membrane permeabilities (independent of CPA concen-
tration and position).
6. Chondrocytes in situ behave similarly as in cell suspensions with re-
spect to osmotic volume excursions. This is indeed the case for a nar-
row range of osmotic concentrations, for which mid-zone bovine
chondrocytes behave as perfect osmometers7,25,26. This assumption
may fail for the larger osmotic changes encountered during stepwise
CPA addition and removal. However, as volume excursions are more
restricted with chondrocytes in situ relative to cells in suspension, de-
signing CPA addition/removal protocols using the properties of cells
in suspension is a more conservative approach in minimizing osmotic
damage to cells by maintaining cell volume within tolerable limits.
7. No soluteesolute interactions for multi-solute CPA transport across
chondrocyte cell membrane or in the tissue matrix; CPA transport is
driven only by its concentration gradient.
8. Concentration-dependence and non-ideality behavior of the solutes in
the tissue similar to those in the bulk; also, ratio of effective diffusivity of
CPA through cartilage to bulk solution diffusivity, Deff/Do, constant.
9. No concentration boundary layer, i.e., concentration at the surface of
the tissue the same as in the bulk solution. This is justiﬁed because
CPA diffusion is slow through the tissue.CPA TRANSPORT ACROSS CELL MEMBRANETo account for transport across the cell membrane, a multi-solute mem-
brane transport model, extended from a two-parameter membrane formal-
ism27, was applied. The ﬂuxes of water and of the ith solute through the
membrane are as follows.Table
Values of model
Parameter Value
Vb 0.414
Lp 0.166
Ps (DMSO, 22(C) 7.88 102
Ps (PD, 22(C) 3.716 102
Ps (FM, 22(C) 7.88 102
Deff (Sucrose, 22(C) 5.49 1010
B (Second virial coefﬁcient) (DMSO) 0.0843
B (Second virial coefﬁcient) (PD) 0.0576
B (Second virial coefﬁcient) (FM) 0.0306dVw
dt
¼LpART
XN
i¼1
ðMei M ii Þ ð2Þ
dNi
dt
¼ Psi AðMei M ii Þ ð3Þ
In the above, Vw (mm
3) is the volume of water inside the cell; Lp (mm/
s atm) the water permeability; A (mm2) the surface area of the cell; R
((mm3 atm)/(mol K)) the universal gas constant; T (K) the absolute temper-
ature; Mi
e and Mi
i (osmoles/kg) the external and internal osmolalities, re-
spectively, of the ith solute; Ni (moles) the intracellular amount of the ith
solute; and Psi (mm/s) the ith solute permeability. Chondrocyte membrane
permeabilities for DMSO and PD were taken from the literature28 and are
shown in Table I. As no data are available on the FM permeability for
chondrocytes, the average of DMSO and PD permeabilities was used
for this solute.CPA TRANSPORT THROUGH CARTILAGE ECMTransport for the ith solute through a cylindrical cartilage plug is described
by the following equation, assuming angular symmetry and no reaction
vCi
vt
¼Deff

1
r
v
vr

r
vCi
vr

þ v
2Ci
vz2

ð4Þ
with the following initial and boundary conditions.
(i) Ci ðr ;z; t ¼ 0Þ ¼ 0 ðno CPA initially present in the tissueÞ ð5Þ
(ii) Ci ðr ¼ R0;z; tÞ ¼ CbulkK ðCPA concentration at the cylindrical surface
equal to that in the liquid bulk times the partition coefficient;K Þ ð6Þ(iii) vCi
vr
ðr ¼ 0;z; tÞ ¼ 0 ðsymmetry condition at the cylinder axisÞ ð7Þ
 (iv)
Ci r ;z ¼L
2
; t ¼ CbulkK ðCPA concentration at the cylindrical basesequal to that in the liquid bulk times K Þ ð8Þ
(v) vCi
vz
ðr ;z ¼ 0; tÞ ¼ 0
ðsymmetry condition at the cylinder mid-planeÞ ð9ÞIn the above, C is the CPA concentration; Deff the effective CPA diffusivity
through the cartilage matrix; r the radial position; R0 the radius of the carti-
lage plug; z the axial position; and t time. If, instead of cartilage, an osteo-
chondral plug with a bone segment of signiﬁcant thickness is considered,
boundary conditions (iv) and (v) become
Ci ðr ;z ¼ L; tÞ ¼ CbulkK ðCPA concentration at the cartilage cylindrical base
equals that in the bulk times K
vCi
vz
ðr ;z ¼ 0; tÞ ¼ 0 ðno CPA flux through the osteochondral interfaceÞ
where the osteochondral interface is at z¼ 0 and the cartilage tissue extends
to z¼ L.I
parameters
Units Source
[e] Ref. 28
[mm/min atm] Ref. 28
[mm/s] Ref. 28
[mm/s] Ref. 28
[mm/s] Average of Ps for DMSO and PD
[m2/s] Ref. 47
[mol/kg]1 Ref. 32
[mol/kg]1 Ref. 32
[mol/kg]1 Coefﬁcient calculated on the
basis of data from Ref. 48
Table II
T1 and T2 values of 6.9 M DMSO in bulk solution and equilibrated in
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THROUGH CARTILAGE MATRIXcartilage
T1 (s) T2 (s)
6.9 M DMSO DMSO 1.99 1.70
Water 1.08 1.05
Equilibrated cartilage tissue DMSO 1.86 0.669
Water 1.07 0.086
Fig. 2. 1H NMR imaging of DMSO diffusion in cartilage. (A) Time
series montage of 1H NMR images from a 1.0 mm thick planar seg-
ment through the center of a cylindrical cartilage plug. Images are
based on detection of DMSO, hence they present the permeation
of this solute from a 6.9 M single-solute solution into the initially
DMSO-free plug. Image 1 was acquired 81 min after exposing the
tissue to the DMSO solution; each subsequent image was acquiredEffective diffusivity, Deff, values were calculated from imaging and spec-
troscopic data as follows. For the imaging experiments, average intensities
were calculated from the images of the 1.0 mm thick slab about the center
of the plug. In the spectroscopy experiments, average concentrations ðCi Þ
came from a 1 1 1 mm3 volume in the center of a cartilage plug. Average
concentrations were calculated by
Ci ¼
R
V
Ci dV
V
ð10Þ
Ci=Cbulk proﬁles were ﬁt using COMSOL Multiphysics (COMSOL, Inc.,
Burlington, MA) with Deff as the adjustable parameter (Eq. (4)) using appro-
priate boundary and initial conditions (Eqs. (5)e(9)), sample dimensions and
integration volumes. Least-squares optimization was used to determine the
best ﬁt for Deff.
Bulk solution diffusivity calculations
High concentration solutions can be thermodynamically non-ideal, having
diffusion coefﬁcients strongly dependent on concentration29. To account for
this, the following equation was used to calculate CPA diffusivities in the
bulk30:
DFickAB ¼ ðGÞðDMSAB Þ ¼

1þ xA

vln gA
vxA

DoAB
ð1þxBxAÞ
2

DoBA
ð1þxAxB Þ
2

ð11Þ
where DFickAB is the Fickian diffusivity (m
2/s) of the binary pair AeB (CPA-
solvent); G the thermodynamic factor which accounts for non-ideality; DMSAB
the MaxwelleStefan (MS) diffusivity which accounts for the concentration
dependency (m2/s); xA the mole fraction of solute; xB the mole fraction of sol-
vent; gA the activity coefﬁcient of the solute; D
o
AB the diffusivity at inﬁnite-
dilution of pair AeB (m2/s); and DoBA the diffusivity at inﬁnite-dilution of pair
BeA (m2/s), which were calculated from the WilkeeChang equation29. Activ-
ity coefﬁcients were calculated using the UNIFAC activity coefﬁcient
model31. Eq. (11) was used to calculate bulk solute diffusivities as a function
of composition for each CPAewater pair. An average diffusivity value was
used between xA¼ 0 and the ﬁnal CPA concentration in the bulk. The ratio
of diffusivities for a CPA between the cartilage and bulk, Deff/Do, could
then be computed. This ratio represents the solute transport resistance
due to the cartilage tissue. As indicated, this ratio was assumed constant
for each CPA in this study.
CPA transport through matrix and across cell membrane
Intracellular solute osmolality and cell volume excursions for chondro-
cytes were simulated as a function of time at chosen points within a clinically
relevant-sized cartilage tissue of 5 mm diameter and 2 mm length. This was
implemented by coupling CPA concentrations in the matrix and intracellular
compartments. The selected points were at the center and periphery of the
tissue, as these represent the extreme locations for CPA equilibration.
Diffusivities used to determine CPA concentration proﬁles were calculated
as follows: Do for each CPA was determined at the particular bulk concentra-
tion as described in the previous section and Deff was calculated by using the
constant Deff/Do hindrance ratio. Concentration proﬁles in the matrix were
generated by COMSOL using the appropriate initial and boundary condi-
tions, and they were coupled with Eqs. (2) and (3) using MATLAB (Math-
works, Natick, MA, USA). Due to the high concentration of VS55, CPAs
were added in a stepwise manner to minimize cell osmotic effects. For
CPA osmolalities, a multi-solute osmotic virial equation was used to account
for solution non-idealities, as in Elliott et al.32. The osmolality calculations (re-
lating CPA concentrations to Mei and M
i
i ) were used in Eqs. (2) and (3) to
predict cell volume and intracellular CPA concentrations. For three solutes,
the osmotic virial equation was extended as follows:
p¼ c1 þ c2 þ c3 þB11c21 þ c1c2ðB11 þB22Þ þB22c22 þ c1c3ðB11 þB33Þ
þ c2c3ðB22 þB33Þ þB33c23 ð12Þ
where p is the osmolality (Osm); c1, c2, c3 the molal concentrations (moles of
solute per kilogram of solvent) for DMSO, PD and FM, respectively; and B1,
B2 and B3 the second osmotic virial coefﬁcients for DMSO, PD and FM, re-
spectively. Virial coefﬁcient values are listed in Table I.51 min from the preceding one. (B) Imaging signal intensity aver-
aged over the acquisition plane (Icartilage), indicated by the horizon-
tal bars at each time point, normalized to the signal intensity in theResults
surrounding solution (Ibulk). Points are experimental measurements
from one imaging experiment. Dashed line is the best-ﬁt curve, us-1H NMR IMAGING AND SPECTROSCOPY
ing least-squares ﬁtting and the DMSO effective diffusivity as the
only adjustable parameter, of a Fickian diffusion model through
the experimental data.Single-solute permeation was monitored by CSSI.
Table II reports the measured relaxation parameters T1and T2. The time constants for DMSO and water were lower
in the tissue than in the bulk, as the tissue causes shorten-
ing of relaxation times. Images that tracked the diffusion of
DMSO (water was not captured in this study) from a 6.9 M
solution into the tissue are shown in Fig. 2(A). The ratio of
brightness intensities in the tissue and in the bulk, Icartilage/
Ibulk [Fig. 2(B)], which is equal to the ratio of concentrations,
Ci=Cbulk, was ﬁt to Eqs. (4)e(9) with K set to 0.9 (based on
the last experimental data point) and with Deff as the only
adjustable parameter. The brightness intensity inside the
tissue increased with time, indicating an inﬂux of DMSO.
Equilibrium between the tissue and the bulk took
Fig. 4. Representative concentration proﬁles of permeating half
strength VS55 (1.55 M DMSO, 1.55 M FM, 1.05 M PD) into AC.
Points are experimental measurements from localized 1H NMR
spectroscopy from a 1 1 1 mm3 VOI positioned in the center
of the plug. Lines are best-ﬁt model simulations using the effective
diffusivity of each component as the only adjustable parameter.
Water was also detected in the 1H NMR spectra (Fig. 3). As the tis-
sue is exposed to a hypertonic CPA solution, water leaves the tis-
1383Osteoarthritis and Cartilage Vol. 16, No. 11approximately 4 h to establish. Evidently, 1H NMR imaging
provides a clear assessment of permeation of a single CPA
solution.
Figure 3 shows a typical 1H spectrum of half strength
VS55, both in the bulk and inside cartilage after equilibra-
tion. The individual solutes are easily distinguishable and
areas under the peaks correlate to the relative concentra-
tions. Figure 4 shows the normalized (relative to the bulk)
concentrations of the individual CPAs in the VOI over
time. At equilibrium, the concentrations of all three CPAs
in the tissue were equal to those in the bulk, consequently,
K was set equal to 1. FM, the smallest solute with molecular
weight 45 Da, diffused the fastest. As water was clearly de-
tected in the spectra (Fig. 3), its concentration in the tissue
was also plotted vs time (Fig. 4, inset). Due to an osmotic
difference between the inside and outside of the tissue, wa-
ter efﬂux occurred. As with the 6.9 M DMSO, VS55 took
2e3 h to equilibrate with the bulk solution. Simulated con-
centration proﬁles (Fig. 4, lines) were generated by solving
Eqs. (4)e(9). In cartilage, solutes diffused at 30e38% of
their rates in the bulk due to hindrance from the matrix.
As the VOI was at the center of the larger tissue specimen,
there was a time lag in the simulated concentration proﬁles
corresponding to the time it took for the solutes to diffuse
from the bulk to the VOI.sue simultaneously as the inﬂux of the VS55 components occurs.
The inset shows the decline in water concentration in the VOI, nor-
malized to the initial water concentration (C/Cinitial), vs time.SIMULATIONS OF CELL VOLUME CHANGE AND
INTRACELLULAR SOLUTE CONCENTRATIONFigure 5 shows simulations of cell volume excursions and
intracellular CPA concentrations for cells at the center and
periphery of a 5 mm diameter and 2 mm thick cylinder of
cartilage after stepwise addition and removal of VS55.
CPA concentrations in the matrix were calculated using
Eqs. (4)e(9), intracellular CPA concentrations were calcu-
lated from Eqs. (2) and (3), and cell volume excursions
were computed as described by Kleinhans27. The partition
coefﬁcient was assumed to be 1, as indicated by the data
in Fig. 4. To maintain osmotic volume excursions within tol-
erable limits, estimated from previous studies33, additionFig. 3. (A) 1H NMR spectrum of half strength VS55 cocktail (1.55 M
DMSO, 1.55 M FM, 1.05 M PD) at 200 MHz in a 1 1 1 mm3 VOI
in AC positioned in the center after CPA equilibration; (B) 1H NMR
spectra of half strength VS55 cocktail in the bulk at 200 MHz in
a 1 1 1 mm3 VOI; inset in B represents a zoom-in of the FM
peak for visualization; D¼DMSO; F¼ FM; P¼PD; W¼water.was carried out in four steps and removal also in four steps,
in the presence of varying concentrations of sucrose
(0.35 M, 0.3 M, 0.2 M, and 0 M), a non-permeating solute
for osmotic buffering. A Deff/Do value of 0.34 was used for
sucrose. The duration of each addition and removal step
was determined so as to minimize the exposure time while
ensuring at least 90% intracellular CPA equilibration for
cells at the center relative to bulk before implementing the
next step. Volume excursions at the periphery were larger
than at the center, as cells at the center experiencedFig. 5. Simulated normalized cell volume and intracellular CPA
osmolality for chondrocytes at the periphery (solid lines) and the
center (dashed lines) of a 5 mm diameter by 2 mm thick cartilage
plug exposed to stepwise addition and removal of VS55 vitriﬁcation
cocktail (3.1 M DMSO, 3.1 M FM, 2.1 M PD). Cell volumes were
calculated assuming that the cells in the tissue behave similarly
as in suspension with respect to osmotic volume excursions.
Fig. 6. Simulated concentration proﬁles of VS55 components in the matrix in a 5 mm diameter by 2 mm thick cartilage plug. Concentration
proﬁles shown for points at the center and periphery of the plug.
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fusion of the solute through the tissue. Figure 6 shows sim-
ulated CPA and sucrose concentrations through the matrix.
The addition and removal of VS55 took over 2 h each at
room temperature.Table IIIA
Effective diffusivities of each component of a multi-solute CPA
solution through cartilage and their ratios to the corresponding
diffusivities in bulk solution (Deff/Do)
Deff (AverageSD)
1010 (m2/s)
Deff/Do
DMSO in single-solute
solution (measurement
by NMR imaging)
3.59 0.31
VS55 cocktail (measurement by
localized NMR spectroscopy)
DMSO 4.63 0.85* 0.34
PD 3.47 0.67* 0.30
FM 6.67 0.70* 0.38
Deff¼ effective diffusivity; Do¼ bulk diffusivity; SD¼ standard
deviation.
*Values are averages SD from three independent
experiments.Discussion
Effective osteochondral tissue banking relies upon suc-
cessful long-term preservation. Conventional freezing and
vitriﬁcation have been met with limited success for cartilage
of clinically relevant dimensions. This study undertook a sys-
tematic modeling methodology, based on experimentally
measured parameter values, to design CPA addition and
removal protocols.
Experimentally, CPA transport was examined by NMR
imaging and spectroscopy, and modeling calculations
tracked two important parameters in ensuring a successful
preservation outcome, namely, cell volume and intracellular
CPA concentration. The partition coefﬁcients measured by
imaging and spectroscopy differed somewhat. The reason
for this discrepancy is unclear; however, different solutions
were used in the two experiments, and solute transport in
the presence of multiple solutes may be different than trans-
port of a single-solute system34.
The effective CPA diffusivities determined in this study
(Table IIIA) were similar to those reported by others (Table
IIIB), although Muldrew et al.20 and Carsi et al.18 reported
higher values. The ratios of CPA diffusivities through carti-
lage to water (Deff /Do) were 0.30e0.40, similar to those re-
ported for other small, non-electrolyte solutes35e37.
Effective diffusivities of 6.9 M DMSO through other tissues,
such as kidney and liver, have been reported to be
180 1010 and 50 1010 m2/s, respectively, under
ambient conditions16. Clearly, the lower diffusivities through
cartilage (Table IIIA) make this tissue more difﬁcult to
preserve.
This study was carried out with immature bovine AC,
which can be easily obtained in thick sections, isinexpensive, and has a relatively homogeneous distribution
of cells. As mature AC is heterogeneous and anisotropic
with respect to both cellularity and extracellular matrix prop-
erties38, studies with mature cartilage are needed. How-
ever, there exists evidence that transport of small,
uncharged molecules is similar in immature and mature tis-
sue. For instance, Torzilli et al. reported that the biochemi-
cal changes brought on by skeletal maturation did not
signiﬁcantly affect the diffusion of glucose and 10 kDa dex-
tran through bovine AC, despite associated changes in the
spatial distribution of interstitial water, extracellular collagen
and proteoglycan content39. Hence, the results of this study
with small (45e78 Da), uncharged solutes are potentially
applicable to mature AC. Similarly, differences in effective
diffusivities and cell membrane permeabilities are expected
to exist with cartilage from other species, so appropriate pa-
rameter values need to be used in each case for designing
the CPA addition and removal protocols. Overall, however,
the time to equilibration is expected to be of same order for
Table IIIB
Effective diffusivities of CPAs through AC from the literature
Source Dimensions CPA Concentration (M) Deff 1010 (m2/s) Temperature ((C) Reference
Mature porcine AC No bone: d¼ 10 mm,
z¼ 2e4 mm; with bone:
d¼ 10 mm, z¼ 7e14 mm
DMSO 6.8 3.5 (with and without bone) 22 41
PD 6.8 2.0 (with bone) 22 41
Immature and
mature human AC
d¼ 10 mm, z¼ 2.2e3.4 mm DMSO 1.4 17.9 37 18
Immature porcine AC d¼ 5 mm, z¼ 2.9e5 mm DMSO 1 11.20 22 20
Immature ovine AC d¼ 6 mm, z¼ 1 mm DMSO 1.4 4.06 22 40
PD 1.4 3.41
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cies and age.
Mathematical modeling was used to determine chondro-
cyte volume excursions and intracellular CPA concentra-
tions at different locations in the cartilage specimen. The
model incorporated multi-component CPAs diffusing across
the cell membrane and non-idealities of the high concentra-
tion CPA solutions. Chondrocytes in tissue probably
undergo smaller volumetric excursions than cells in suspen-
sion for the same step changes in CPA concentration.
Hence, it is possible that the number of CPA addition/re-
moval steps could be reduced, however, basing the calcu-
lations on the properties of cells in suspension is a more
conservative approach for minimizing osmotic damage to
cells. This information coupled with cytotoxicity data (cell
death from CPA exposure as function of time, concentration
and temperature) could optimize exposure to CPA for max-
imal cell viability with sufﬁcient intracellular CPA concentra-
tion for vitriﬁcation. Recent work showing the impact of ﬁxed
charge density on CPA permeation into AC40 could also be
incorporated in the model structure.
The diffusivity measurements in this study were carried
out at room temperature. Often CPAs are added and/or re-
moved at 0e4C to reduce CPA cytotoxic effects. The dif-
ferent effects of temperature on mass transport and
cytotoxicity pose an optimization problem, as at lower tem-
peratures CPA cytotoxicity is reduced but the time to equil-
ibration is increased. Knowing the temperature dependence
of CPA transport and cytotoxicity would allow the present
model to be extended in designing CPA addition/removal
protocols by manipulating both concentrations and temper-
ature in the bulk.
Cryopreservation of biological materials deals with mass
transport of CPAs and heat transport during cooling and
thawing. Diffusion of CPAs into cartilage tissue is slow
[this study, Refs. 35e37], so chondrocyte survival is limited
to the superﬁcial layer2,4,42 or to both superﬁcial and deep,
but not the intermediate, zones43. Cell survival could be im-
proved by enhancing CPA transport, for example by intro-
ducing convection by boring holes into the tissue44.
Diffusion of CPAs is faster in tissue engineered cartilage45,
therefore cryopreservation of the latter might be easier to
accomplish. With regard to heat transport, preliminary
data from our lab (unpublished) and Johma et al.46 suggest
that temperature equilibration occurs in minutes, as op-
posed to hours for CPA equilibration. However, heat trans-
port is critical and further studies are needed to characterize
its role in cartilage cryopreservation.
In conclusion, this study used experimentally measured
diffusivities of CPAs through AC, which were incorporated
in mathematical models simulating multi-step addition and
removal. This study constitutes a ﬁrst step toward the even-
tual goal of developing, optimizing and validating models of3-D tissue cryopreservation based on parameters that are
accurately measured experimentally.Conﬂict of interest
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